Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

[Pharmacotherapy of Parkinson's disease].

Ceballos-Baumann A.

MMW Fortschr Med. 2013 May 2;155(8):49-51. Review. German. No abstract available.

PMID:
24437138
2.
4.

Measuring motor complications in clinical trials for early Parkinson's disease.

Marras C, Lang AE.

J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):143-6. Review. No abstract available.

5.

Parkinson's disease.

Clarke C, Moore AP.

Clin Evid. 2002 Jun;(7):1208-20. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):1370-85.

PMID:
12230738
6.

Parkinson's disease.

Clarke C, Moore A.

Clin Evid. 2002 Dec;(8):1370-85. Review. No abstract available. Update in: Clin Evid. 2003 Dec;(10):1582-98.

PMID:
12603943
7.

Broad bean (Vicia faba)--a natural source of L-dopa--prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations.

Apaydin H, Ertan S, Ozekmekçi S.

Mov Disord. 2000 Jan;15(1):164-6. No abstract available.

PMID:
10634260
8.

Recent advances in the treatment of Parkinson's disease.

Martocci RJ.

J Am Osteopath Assoc. 1975 Apr;74(8):730-41. Review. No abstract available.

PMID:
1092751
9.

Treatment of Parkinson's disease should begin with a dopamine agonist.

Montastruc JL.

Mov Disord. 2000 Mar;15(2):361-2. No abstract available.

PMID:
10752600
10.

Response to L-dopa in PD: the long and the short of it.

Nutt JG.

Neurology. 2000 May 23;54(10):1884-5. No abstract available.

PMID:
10822422
11.

Continuous duodenal infusions of levodopa.

Fowler SB, Bergen M.

J Neurosci Nurs. 1993 Oct;25(5):317-20.

PMID:
8270813
12.

Therapeutic dilemma: psychosis and Parkinson's disease.

Damecour CL, Turcotte JR.

Can J Psychiatry. 1995 Dec;40(10):640-1. No abstract available.

PMID:
8681265
14.
15.

The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.

Stocchi F.

Expert Opin Pharmacother. 2006 Jul;7(10):1399-407. Review.

PMID:
16805724
16.

Parkinson's disease: recent advances in therapy.

Jankovic J.

South Med J. 1988 Aug;81(8):1021-7. Review. No abstract available.

PMID:
3043683
17.

Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.

Allain H, Destée A, Petit H, Patay M, Schück S, Bentué-Ferrer D, Le Cavorzin P.

Eur Neurol. 2000;44(1):22-30.

PMID:
10894991
18.

Levodopa for Parkinson's disease.

Devos D, Moreau C, Destée A.

N Engl J Med. 2009 Feb 26;360(9):935-6; author reply 936. doi: 10.1056/NEJMc082718. No abstract available.

19.

Choice of treatment in Parkinson's disease.

Stern GM, Lees AJ.

Practitioner. 1977 Oct;219(1312):537-41. No abstract available.

PMID:
594012
20.

Adjuncts to levodopa therapy: dopamine agonists.

Poewe W.

Neurology. 1998 Jun;50(6 Suppl 6):S23-6; discussion S44-8. Review.

PMID:
9633683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk